David Foster, Ph.D., J.D.
Dr. Foster has over 19 years of experience in the development and commercialization of healthcare products. He works with a number of biotech startups. Dr. Foster is co-founder and active Board member of BioNorth Texas. In addition, Dr. Foster is co-founder and partner of the boutique law firm, Roberts Foster LLP, focused on providing legal services for emerging technology companies. Prior to that, Dr. Foster spent several years in private legal practice providing IP strategy for a number of emerging biotechnology companies. In addition, Dr. Foster served as a patent counsel at Medarex, Inc. where he was an integral member of project teams developing novel checkpoint inhibitor protein biotherapeutics. At Medarex, Dr. Foster provided counsel on IP due diligence and strategic patent prosecution matters that contributed to
Kurt L Berens
Mr. Berens has over twenty-five years of experience in the development and commercialization of biopharmaceutical and medical device products. Mr. Berens has been part of development teams that received registration and marketing approval for two ethical drug products (Argatroban® [US], Thelin® [EMEA]) and one medical device (Galileo® System centering catheter and intracoronary brachytherapy system). Mr. Berens conducted research and development on novel drug dosage forms and delivery technology for NASA and served as the Manager for Cellular and Biomedical Section in the Bioastronautics Group at Johnson Space Center in Houston, TX. Mr. Berens has also served as Senior Project Manager at Texas Biotechnology Corporation, as Vice President, Product Development, at CytoGenix, Inc. and is currently Chief Operating Officer of Tuevol Therapeutics, Inc. Mr. Berens received his BA from the University of Minnesota with post-graduate training in Pharmaceutics at the University of Houston. Mr. Berens is a co-author
Ioannis Skaribas, M.D.
Medical Scientific Advisor
Dr. Ioannis Skaribas earned his medical degree at Aristotelian University of Thessaloniki Medical School in Greece. He completed a 4-year Anesthesiology residency in Athens Greece, and obtained board certification before moving to the US. In Houston, he completed an internship in anesthesiology and a residency in Anesthesiology at Baylor College of Medicine. During his residency, he received the “Intern of the Year” award. After his residency he completed a ACGME accredited interventional fellowship in pain medicine at Baylor College of Medicine.
Double Board certified in Anesthesiology and Pain Medicine, Dr. Skaribas specializes in Interventional Pain therapies. His clinical interests include spinal cord stimulation, and neuromodulation as well as intraspinal interventional therapies and treatment of intractable Headaches.
Dr. Skaribas has an appointment as a clinical assistant professor in pain medicine at The University of Texas Health Science Center at Houston, and serves on the board of directors of the Memorial Hermann Sugar Land Surgery Center. He has served as an assistant professor of anesthesiology at BCM. Until March of 2018 he has been a partner physician and shareholder with US Anesthesia Partners. He has served as the medical director of the Pain Management branch of USAP.
In 2018 he founded Expert Pain P.A., a consortium for advanced pain management interventions and where he serves as the medical director and CEO.
The author of several textbook chapters and journal manuscripts, Dr. Skaribas is a member of local, national and international professional medical societies including the Texas Pain Society, Harris County Medical Society, International Neuromodulation Society, American Board of Anesthesiology and American Society of Interventional Pain Physicians.